StockData
Trulieve Cannabis Corp. logo

Trulieve Cannabis Corp. (TRLV) stock

TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/308% below fair value
$11.15−0.08 (-0.71%)

Close on Nov 12, 2026Market cap $2.15BP/E –Yield –

Trulieve Cannabis Corp. saw revenue fall 9.1% to $1.08B over the twelve months to Sep 30, 2026. Operating income fell 313.9% to -$277.01M, moving the operating margin from 10.9% to -25.6%. Free cash flow was $188.18M, up 27.0% from a year earlier. At the latest close the market valued the company at $2.15B.

Revenue
$1.08B
-9.1% vs. a year earlier
Operating income
-$277.01M
-313.9% vs. a year earlier
Free cash flow
$188.18M
+27.0% vs. a year earlier
EPS, diluted
-$2.32
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$2.15B
P/E ratio
–
Price to sales
1.99
Price to book
–
Dividend yield
–
Free cash flow yield
8.76%

Fundamentals

Revenue
$1.08B
EPS, diluted
-$2.32
Free cash flow
$188.18M
Diluted shares
201M

Trading

Next earnings
Feb 25, 2027 (estimated, before the open)
Previous close
$11.23
Open
$11.11
Day's range
$10.56 – $11.19
Volume
1,793,087
Average volume (20 days)
1,349,504
Beta (5 years)
1.15
52-week range
$4.62 – $13.28
RSI (14 days)
52.2
Volatility (1 year)
109.2%
Relative volume
1.18×
WACC
10.7%

On 1 of our idea list: Institutions accumulating

Market cap history

Month-end market cap since 2020, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodTRLVS&P 500DifferenceTRLV per yearS&P 500 per year
1 month+7.3%-2.7%+10.0 pts
3 months+22.4%-1.7%+24.1 pts
Year to date+28.3%+11.9%+16.4 pts
1 year+62.1%+12.0%+50.1 pts
3 years+106.5%+78.2%+28.3 pts+27.3%+21.2%
5 years-64.0%+73.2%−137.2 pts-18.5%+11.6%

Seven years at a glance

Fiscal years 2019 to 2025 and trailing twelve months, USD

Revenue

$1.08B-9.1% YoY

Gross profit

$655.56M-9.3% YoY

Operating income

-$277.01M-313.9% YoY

Net income

–

EPS, diluted

-$2.32

Free cash flow

$188.18M+27.0% YoY
Reported periodTrailing twelve months

Press releases

Releases Trulieve Cannabis filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Trulieve Cannabis

Medicinal Chemicals & Botanical Products

Trulieve Cannabis Corp. is a vertically integrated cannabis operator that cultivates, processes, manufactures, and distributes medical and adult-use cannabis products. The company produces cannabis flower, oils, and concentrates through extraction, distillation, and purification methods. It distributes these goods under proprietary brand tiers such as Avenue, Cultivar Collection, Muse, Modern Flower, Momenta, Sweet Talk, Co2lors, and Roll One, while also distributing partner brands. Trulieve serves qualified medical cannabis patients and recreational adult consumers aged 21 and older through retail dispensaries and wholesale channels.

Company profile, executives and history

Trulieve Cannabis stock: common questions

What is Trulieve Cannabis's stock price?

TRLV closed at $11.15 on Nov 12, 2026, down 0.71% on the day. Over the past 52 weeks it traded between $4.62 and $13.28.

What is Trulieve Cannabis's market cap?

Trulieve Cannabis was worth $2.15B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

What is TRLV's P/E ratio?

Trulieve Cannabis lost money over the twelve months to Sep 30, 2026 (diluted EPS -$2.32), so it has no meaningful P/E ratio.

How much revenue does Trulieve Cannabis make?

Trulieve Cannabis reported revenue of $1.08B for the twelve months to Sep 30, 2026, down 9.1% from a year earlier.

Does Trulieve Cannabis pay a dividend?

No. Trulieve Cannabis has not paid a cash dividend over the last twelve months.

When does Trulieve Cannabis report earnings next?

Trulieve Cannabis is expected to report Q4 FY2026 results on Feb 25, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has TRLV stock performed over the past year?

Including dividends, TRLV returned +62.1% over the past year, against +12.0% for the S&P 500.

How many TRLV shares are sold short?

4M shares were sold short at the latest FINRA report, 2.11% of the float, or 3.4 days of average trading volume.

Who are Trulieve Cannabis's competitors?

Companies most similar to Trulieve Cannabis by business, industry and size include CURLF, CRLBF, JUSH, AAWH, TLRY.

See a number that looks wrong?